‌

1812

Alpharma Inc. agreed to pay 42.5 million to resolve False Claims Act allegations in connection with the marketing of the morphine-based drug Kadian. The settlement resolved allegations that between January 1, 2000 and December 29, 2008 Alpharma paid health care providers to induce them to promote or prescribe Kadian, and made misrepresentations about the safety and efficacy of the drug.

Last sale

Holder

0xe5...6238

HODLed for

2 years

Fees

There were no sales for this token

Details

Created

Jun 30th, 2022, 03:27

Blockchain

ETH

Storage

decentralized

Token standart

ERC-721

Metadata

View

Unlockable content

Rarity

Rarity score

3.39%

Rarity rank

# 9719 / 10000

Trait count

What is the value?

Price

Sales

Sales (All)

N/A

Avg collection sales (All)

N/A

Difference

N/A

Collectible last sale price

Collection avg price (All)

Difference

N/A

Collectible last sale price

Collection min price (All)

Difference

N/A

Successful royalty payments

Skipped royalty payments

Difference

N/A

Activity history

Processing data. Please, come back later.

‌

Overall Score

Critical Risk

‌

Critical Risks

‌

Medium Risks

‌

Low Risks

Details

‌

Collection Sales

0 sales per last month

‌

Metadata Storage

Decentralized storage

‌

Creator Royalty

7.5%

‌

Artifact Storage

Decentralized storage

‌

Unique Owners

Collection tokens10000 tokens

Unique Owners453 / 4.53%

‌

External Contract

Custom contract

‌

Token Type

ERC-721

‌

Editable Metadata

Not editable metadata stored on ipfs or blockchain

‌

Suspicious Sales

0 potential sales

‌

Missed Royalty Payments

0% missed royalty fee

‌

Copymints

The original collection.

Found 0 similar collections

More Risks and Alerts parameters coming soon